The research group led by Dr. Soravia focuses on developing psychobiological approaches that integrate effective psychotherapy methods with innovative and synergistic substance administration for treating mental disorders. Dr. Soravia specializes in psychotherapy, psychedelics, and psychoneuroendocrinology, with a particular interest in understanding the neuronal mechanisms underlying treatment responses. Their research primarily targets substance use disorders, stress- and trauma-related conditions, and anxiety. By bridging neurobiological and neuroendocrinological insights with clinical practice, the research group aims to enhance psychotherapy processes and optimize treatment outcomes.
